π You order a diagnostic test with LR+ = 20. Pretest probability = 30% β post-test probability?
Pretest odds = 0.3/0.7=0.43 β post-test odds = 0.43Γ20=8.6 β probability β 90% β strong rule-in.
π A systematic review of RCTs shows heterogeneity (IΒ²=85%). Next step?
Explore sources of heterogeneity (different populations, interventions), consider random-effects model, avoid pooling if clinically diverse.
π― Which study design best answers therapy question?
Randomized controlled trial (RCT) with concealment, blinding, and intention-to-treat analysis. Systematic review of RCTs provides highest level.
π βAll-or-noneβ evidence (Level 1c)
Example: when all patients died before therapy, now some survive; or some died before, now none die. Very powerful observational evidence.
π Sensitivity vs specificity β which rules out disease?
High sensitivity test (SnNout): negative result rules OUT disease. High specificity test (SpPin): positive result rules IN disease.
π Cochrane Library key features
2900+ systematic reviews (2006), updated quarterly, minimizes bias. Cochrane Child Health Field supports pediatric reviews.
β οΈ Why are many pediatric RCTs underpowered?
Smaller disease incidence, ethical constraints, heterogeneity of age, lack of validated pediatric outcome measures. Call for multicenter trials and networks (MCRN).
π Bayesian reasoning in clinical history
Each piece of history updates disease probability. Like βDr Jenkinsβ hunchβ β motherβs word βstrangelyβ raised pretest probability for meningococcal sepsis.